Achieve Life Sciences, Inc. (ACHV) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ACHV Revenue Growth
ACHV Revenue Analysis (2014–2025)
As of May 8, 2026, Achieve Life Sciences, Inc. (ACHV) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, ACHV's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $27.1 million in 2014.
When compared to Healthcare sector peers including PTGX (-91.5% YoY), ATAI (+811.8% YoY), and GFAI (+4.0% YoY). Compare ACHV vs PTGX →
ACHV Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ACHVCurrent | $0 | - | - | - | |
 PTGX | $46M | -91.5% | +10.0% | -343.6% | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 GFAI | $36M | +4.0% | -1.2% | -18.5% | |
 OWLT | $106M | +26.8% | +7.0% | -7.9% | |
 CHRS | $42M | -78.1% | -38.4% | -429.5% |
ACHV Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $0 | - |
| 2024 | $0 | - | $-229,000 | - | $-39,069,000 | - |
| 2023 | $0 | - | $0 | - | $-27,250,000 | - |
| 2022 | $0 | - | $0 | - | $-40,800,000 | - |
| 2021 | $0 | - | $0 | - | $-33,094,000 | - |
| 2020 | $0 | - | $-255,000 | - | $-14,750,000 | - |
| 2019 | $0 | - | $-254,000 | - | $-16,528,000 | - |
| 2018 | $0 | - | $-282,000 | - | $-12,813,000 | - |
| 2017 | $0 | -100.0% | $-282,000 | - | $-6,632,000 | - |
| 2016 | $5.1M | -72.1% | $5.1M | 100.0% | $-21,192,000 | -418.6% |
See ACHV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACHV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACHV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACHV — Frequently Asked Questions
Quick answers to the most common questions about buying ACHV stock.
Is ACHV's revenue growth accelerating or slowing?
ACHV TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ACHV's long-term revenue growth rate?
Achieve Life Sciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ACHV's revenue distributed by segment?
ACHV reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.